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ABSTRACT OF THESIS

INVESTIGATION OF THE TOXICITY AND EFFLUX
OF POLYCHLORINATED BIPHENYLS AND HYDROXYLATED
POLYCHLORINATED BIPHENYLS IN ESCHERICHIA COLI

Polychlorinated biphenyls (PCBs) are persistent organic pollutants. Due to
their properties, PCBs accumulate in the food-chain and post a threat to the health of
human beings and wildlife. Hydroxylated PCBs (OH-PCBs) are oxidative metabolites
of PCBs and are more hydrophilic than their parent PCBs. One of the best approaches
to break down these contaminants is through bioremediation, which is an
environmental friendly process that uses microorganisms to restore natural
environment.
Towards this goal, we have investigated the toxicity and accumulation of
PCBs and OH-PCBs in a Gram-negative bacterium, Escherichia coli. We have also
determined the role played by a primary multidrug efflux transporter AcrB on the
accumulation of PCBs and OH-PCBs in bacterial cell. We found that none of the
PCBs tested was toxic to E. coli, while different OH-PCBs have different levels of
toxicity; the acrB knockout strain accumulated significantly more PCBs and
OH-PCBs than the wild-type strain, suggesting that these compounds are substrates of
the efflux pump; higher cytoplasmic concentrations of OH-PCBs were also observed
in the acrB knockout strain using the biosensors. Based on these observations, we
conclude that both PCBs and OH-PCBs are substrates of protein AcrB. Therefore the
efflux activities of multidrug resistant pumps in Gram-negative bacteria should be
considered while designing bioremediation approaches.
KEYWORDS: Polychlorinated biphenyls, hydroxylated polychlorinated biphenyls, E.
coli, Multidrug Efflux Pump, Protein AcrB
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Chapter I: Introduction

1.1 Polychlorinated biphenyl (PCB), an environmental pollutant

PCBs are a group of synthetic compounds that are among the most notorious
environmental contaminants. PCBs were widely used in industrial applications,
particularly as electrical insulating and heat-exchange fluids in transformers and heat
insulators since 1920s [Kucewicz, 2004]. Concerns over PCBs developed in 1965
after the detection of trace amount of these compounds in wildlife in Sweden [Jensen,
1969]. Later in 1979, upon the identification of PCBs in environmental samples, U.S.
government banned the production of PCBs and began to strictly regulate the use of
PCBs in industry. However, due to years of intensive use, improper disposal, and the
intrinsic resistance of the compounds to degradation, large quantities of PCBs remain
in the natural environment, corresponding to one-third of the 1.1 billion tons of PCBs
ever produced [Weigel and Wu, 2000]. PCBs can be found in air, water, soils, and
wildlife, posing a threat to all living creatures.

Because of their highly hydrophobic nature, PCBs preferentially adsorb on the
surface of sediment at the bottoms of rivers. After being ingested by bottom feeders,
PCBs accumulate along the food chain and circulate in the global ecosystem. PCBs
have been found in about one-third of the Superfund National Priorities Sites [EPA,
2000]. Although considerable efforts have focused on cleaning up PCBs from the
environment over the past couple of decades, large amount of PCBs still exist in the
environment, threatening the well-being of both humans and wildlife [Ballschmitter,
1991].

1.1.1 Structure and property of PCBs

There are 209 PCB congeners. All PCB molecules have a biphenyl backbone
as shown in Figure 1.1. Except for the two carbons that serve as the connecting sites,
1

the other ten carbons may attach either a hydrogen or a chlorine atom. According to
the IUPAC nomenclature, the ring with more substitutions or substitutions that occur
on carbons with smaller numbers in the biphenyl assembly is given unprimed
numbers and the other ring with primed numbers. It has been found that the higher the
degree of chlorine substitution, the harder the corresponding PCB to degrade. As a
consequence, the most common PCBs that are detected from exposed animals are
usually

with

high

levels

of

chlorination,

including

2,

2’,

3,

4,

4’,

5-hexachlorobiphenyl, 2, 2’, 4, 4’ 5, 5’-hexachlorobiphenyl, and 2, 2’, 3, 4, 4’, 5,
5’-heptachlorobiphenyl [McFarland and Clarke, 1989].

In terms of structures, PCBs fall into two categories: co-planar structures
(dioxin-like PCBs) and non-planar structures (non-dioxin-like PCBs). The toxicity of
co-planar PCBs is much higher than that of non-planar PCBs [Safe, 1993]. As for the
synthesis of PCBs, two main methods have been adopted, including ferric ion and
iron-catalyzed chlorination of biphenyls [Schaeffer, et al. 1984]. The chlorination is
nevertheless non-region specific, which results in the formation of a complex mixture
of isomers and congeners [Safe, 1993].

Figure 1.1. The general structure of PCBs.

PCBs are chemically inert to different types of chemical reactions including
oxidation, reduction, addition, and substitution. They are also resistant to treatments

2

with acid, base, and heat. These qualities make PCBs very desirable in industrial
applications, especially for the manufacturing of coolants and lubricants. However,
these characteristics also make PCBs persistent environmental pollutants since they
do not readily break down when exposed to chemical treatments or heat. Another
characteristic that makes PCBs notorious pollutants lies in their hydrophobicity. They
tend to accumulate in the fat tissues of oily fish (e.g. salmon, herring, sardines, tuna,
and swordfish). PCBs in tissues from animals higher in the food chain that consume
these fishes may reach a concentration that is many thousands of times higher than the
PCB concentration in water. PCBs have been found all over the world including in the
Arctic and Antarctic regions [Kucewicz, 2004]. Recently, it was reported that high
levels of PCBs were found in polar bears [Skaare, et al. 2000]. Fish is also a food
source for humans. Thus, it is not a surprise that detectable amounts of PCBs are
widely found in human serum, adipose tissue, and breast milk, particularly from those
who often consume contaminated fish [Buck, et al. 1997].

1.1.2 Adverse health effects of PCBs

Scientists have established connections between PCB exposure and adverse
health effects. Laboratory animals have been shown to develop tumors under
conditions of high-dose PCB exposure. U.S. Environmental Protection Agency, as
well as other governmental or advisory agencies, classified PCBs as known animal
carcinogens and possible human carcinogens. PCBs also attribute to eye irritations
and skin disorders, such as chloracne in workers who were exposed to high levels of
PCBs by skin contact and /or inhalation [James, 1993].

Excessive exposure to PCBs also affects the nervous system, immune system,
reproductive system, and endocrine system. Studies with monkeys and humans reveal
that exposure to PCBs leads to deficits in neurological development and changes in
activity [Kimbrough, 2001]. PCBs have also been shown to suppress the immune
system and therefore increase the risk of infections [EPA, 2008]. Reproductive defects
3

have been studied in a variety of animal species as well as humans who were exposed
to PCB. Women who worked with PCBs in factories gave birth to children with
decreased birth weights and gestational age [EPA, 2008]. PCBs have also been
associated with type-2 diabetes through a study involving Swedish fishermen who
consume contaminated fish from Baltic Sea [Lee, et al. 2006]. A positive correlation
between levels of PCBs in their serum and prevalence of type-2 diabetes in the
population has been established [Rylander, 2005].

1.1.3

Bioremediation of PCB contamination sites

Traditional methods to remedy PCB contamination sites include incineration,
vitrification, solvent extraction and land filling [ATSDR, 1993]. However, these
methods have the disadvantages of being time-consuming, expensive, and incomplete.
In the last decade, many researchers began to focus on the development of an
alternative approach to break down PCB wastes using microbes.

Microorganisms belonging to both Gram-negative and Gran-positive genera
including

Pseudomonas,

Alcaligenes,

Achromobacter,

Rhodococcus,

Corynebacterium, and Bacillus have been isolated from PCB contaminated sites
[Unterman, et al. 1996]. These microbes are capable of growing on biphenyl as the
sole carbon source. In 1973, Ahmed and Focht first reported that Achromobacter is
capable of degrading several PCBs [Ahmed, et al. 1973]. Thereafter, the
biodegradation of PCBs was explored from two aspects, dechlorination by anaerobic
bacteria and oxidative degradation by aerobic ones [Furukawa and Fujihara, 2008].

The aerobic PCB degradation bacteria have a bph gene cluster which is
present on their genomes or plasmids. These genes code for enzymes that are capable
of catalyzing different steps of the reaction. Along the biphenyl degradative passway,
one chlorinated benzoic acid and one dienoic acid are generated from the degradation
of one chlorobiphenyl molecule as shown in Figure 1.2 [Gu, et al. 2004]. In terms of
4

dechlorination, microorganisms such as Dehalococcoides and Thermotogales are able
to remove flanking chlorines on several PCBs. Dechlorination is expected to reduce
the toxicity of PCBs as well as making them more susceptible to aerobic
degradation[Liu, et al. 2010].

Figure 1.2. Biodegradation of PCBs catalyzed by Bhp proteins. One molecule of cis-2,
3-dihydro-2, 3-dihydroxychlorobiphenyls is generated from chlorobiphenyl in the presence of
BphA. BphB catalyzes the next step to produce 2, 3-hydroxychlorobiphenyl. BphC and BphD
catalyzes the next two steps of reactions and eventually generate one chlorobenzoic acid and one
2-hydroxy-penta-2, 3-dienoic acid [Gu, et al. 2004].

1.2 Hydroxylated polychlorinated biphenyls (OH-PCBs)

OH-PCBs are hydroxylated metabolites of polychlorinated biphenyls, with a
common structure shown in Figure 1.3. The major metabolic pathway of PCBs is
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biotransformation mediated by the cytochrome P450 isozymes, the terminal oxidases
of the hepatic mixed-function oxidase system, to form hydroxylated PCBs [Lehmler,
et al. 2010]. Even the most persistent PCB congeners can be transformed into a
number of hydroxylated metabolites over time. Aerobic microorganisms degrade
PCBs through another metabolic pathway to generate OH-PCBs with two hydroxyl
substitutions on the parental PCBs, which are catalyzed by terminal dioxygenases.
Furthermore, these OH-PCBs undergo degradation to form chlorinated benzoic acids
[Furukawa and Fujihara, 2008]. Abiotically, OH-PCBs may form via reactions of
gaseous PCBs with OH radicals generated by UV degradation of ozone [Ueno, et al.
2007]. An inverse relationship between PCB concentration and OH radicals in the
contaminated atmosphere has been reported, suggesting the hydroxylation of PCBs as
the major removal pathway for PCBs in the atmosphere.

Figure 1.3. The general structure of monohydroxylated PCBs.

There are 837 possible monohydroxylated polychlorinated biphenyl congeners
compared to 209 PCB congeners. The presence of hydroxyl groups renders these
compounds more hydrophilic than their parent PCBs. Due to increased solubility,
OH-PCBs are more readily absorbed from food source. The concentration of
OH-PCBs in the environment is approximately 2.5 times higher than the
concentration of PCBs [Turner, et al. 2007]. Higher concentrations of OH-PCBs were
also detected in human and animal plasma than their parental PCBs [Park, et al 2009].
As discussed above, PCBs mainly accumulate in adipose tissues. However,
6

OH-PCBs are more water soluble than their parent PCBs, and therefore have a
different distribution in the body. Most OH-PCB congeners are readily conjugated and
excreted. They are able to circulate with blood, cross blood-placenta barriers and
reach various organs [Dreiem, et al. 2009]. Due to structural similarities, OH-PCBs
are antagonist of several hormones, especially thyroxin (Figure 1.4). Studies have
revealed a significant reduction of thyroid hormone levels in plasma of animals
exposed to OH-PCBs. It has been found that OH-PCBs can bind to human
transthyretin (TTR), a thyroid hormone transport protein, with an affinity even higher
than the natural ligand thyroxin [Brouwer and Van den Berg, 1986]. Some OH-PCB
congeners show estrogenicity and antiestrogenicity in various mammalian cells,
which can inhibit gap junctional intercellular communication, activate aryl
hydrocarbon and estrogen receptors, and eventually play a role in tumor promotion
[Machala, et al. 2004]. Furthermore, studies have shown that PCB metabolites
including OH-PCBs and PCB quinones bind to nucleophiles, such as glutathione
(GSH), and inhibit topoisomerase II in vitro. As a consequence, cell susceptibility to
oxidative damage increases due to the depletion of radical scavengers such as GSH
[Srinivasan, et al. 2002]. In in vitro studies, the oxygen species (ROS) generated by
OH-PCBs have also been shown to attack cellular DNA and other nucleophiles,
resulting in oxidative damage, such as DNA strand breakage [Srinivasan, et al. 2001].

Figure 1.4. Structure of thyroxin shows similarity with OH-PCBs.

1.3 Detection methods for PCBs and OH-PCBs
7

With increasing public concerns over environmental accumulation and toxic
effects of PCBs and OH-PCBs, much effort has been focused on developing
techniques and methods to monitor these contaminants. Traditional methods used to
detect PCBs and OH-PCBs include gas chromatography (GC) or high performance
liquid chromatography (HPLC) coupled with mass spectroscopy [Berger, et al. 2004].
These methods require pretreatments of samples through extraction, cleanup, and
derivatization. GC in combination with a compound specific detector is considered as
the primary detection technique for PCBs. It requires the compounds to be thermally
stable at the temperature at which the analyzed samples are being vaporized. The
detection of OH-PCBs by GC/MS on the other hand requires a derivatization step due
to their low volatility. Recently, a two-dimensional gas chromatography (GCGC)
method has been developed to solve the problem of insufficient resolution of GC/MS.
The GCGC system has higher sensitivity, enhanced separation capacities, and
simplified sample preparation process [Harynuk and Marriott, 2006]. LC/MS/MS
system is usually utilized when GC/MS is not applicable due to thermolability, low
volatility and high polarity of target analytes, such as in the detection of
dihydroxylated PCBs. Overall, despite considerable cost and labor intensive sample
preparation

steps,

traditional

analytical

methods

involving

gas

or

liquid

chromatography and mass spectrometry are highly sensitive and reproducible in the
detection of target pollutants in the nano-gram per liter range [Beyer and Biziuk,
2008].

On the other hand, biosensors are becoming more and more popular in the
analyses of environmental and laboratory samples due to multiple advantages,
including simplified sample preparation, rapid analysis, high selectivity, and low cost
[Liu, et al. 2010]. Furthermore, these biosensing systems, especially whole-cell
sensing systems, can provide information on bioavailability and toxic effects of the
analytes to a “living” organism, which is not easily assessed by other cell-disrupting
methods.
8

Biosensors are sensing systems or devices that involve the utilization of
biological components, such as antibodies, enzymes, and receptors as the recognition
or trapping elements [Daunert, et al. 2000]. In the presence of specific targets, the
transducing elements that are connected to the recognition components, such as a
binding protein, will produce measurable signals. The intensity of the signal is
correlated with the amounts of the specific targets. The biological sensing element
therefore confers selectivity while the transducing element determines the sensitivity
in the biosensor. Although the selectivity of biosensors is comparable or even higher
than traditional chromatography methods, the relatively low sensitivity, difficulties
with immobilizing the recognition element and limited shelf-life are some challenges
that limit wide applications of biosensors [Namiesnik, 2001].

1.4 Whole-cell biosensing system

Whole-cell sensing systems offer many benefits over other types of biosensors.
First of all, other biosensors and traditional chromatography methods usually measure
the total concentrations of analytes. However, living organisms are not always
actually exposed to such a high amount of analytes, particularly when the target
analytes have low bioavailability. These results thus might overestimate the actual
effective amount of the analyte that may affect the living environment of humans and
wildlife. Living cells, on the other hand, can reflect the bioavailability of the analytes
and their toxic effects more accurately. Secondly, owning to the self-reproducing
ability of microorganisms, whole-cell sensing systems have advantages such as low
cost and lack of need for complex regeneration [Van der Meer, et al. 2004].

Microorganisms thriving in an environment with elevated concentration of
chemicals have evolved different mechanisms to survive [Nikaido, 2009]. For
example, many microbes living in hospitals have achieved increased resistance to
multiple antimicrobials. The increased tolerance to alien chemicals could be a result
9

of an active efflux system that prevents the chemical from building up in their cytosol
or special enzymes that degrade the compounds. The efflux pumps or enzymes
involved in these mechanisms are usually encoded in the genome or plasmids of these
microorganisms. However, the expression of these defense proteins is usually not
constitutive. They are only produced in the presence of target compounds. The
sensing

and

transcription

regulation

mechanism

from

different

types

of

microorganisms have been exploited in the design of whole cell sensing systems for
various toxic metals such as arsenic, antimony, mercury and lead, and organic
aromatic compounds such as hydroxylated PCBs and chlorocatechols [Date, et al.
2007].

In term of detection mechanisms, there are mainly two types that can be
employed in the whole-cell biosensors, the constitutive expression mechanism and the
inducible expression mechanism [Gu, et al. 2004]. The constitutive expression system
expresses the reporter protein at all times and yields a signal constantly. Toxic
compounds, once present in the microorganism growing environment, will interfere
with the growth of cells. The resultant decrease of cell density is reflected from the
reduction of the signals. By generating a standard curve, the concentration of toxic
targets can be measured. The constitutive expression system is not very selective, as it
will detect the presence of any toxin that affects the growth of cell. Therefore, it is
useful in the assessment of the overall contents of toxic compounds in a sample. A
mammalian cell line harboring a plasmid PEGFP-N2, in which GFP gene is under the
transcriptional control of the CMV promoter, has been constructed [Bi, 2002]. Using
this cells line, the toxicity of many chemicals was characterized. Under harmful or
toxic conditions, cells exhibited a lower growth rate and metabolism, which was
reflected from a decreased fluorescence value.

In the inducible expression system, no signal can be detected in the absence of
target compounds. The presence of the target compound triggers the expression of
reporter proteins, which leads to detectable signals. The inducible expression system
10

is highly specific to analytes that induce the expression of the reporter protein. To
construct a whole-cell biosensor of the inducible expression system, a special plasmid
is usually created which includes a reporter gene under the control of a promoter as
well as the gene coding for the corresponding regulator (Figure 1.5).

Figure 1.5. Plasmid designed for whole-cell biosensor. A regulator is placed upstream of a
promoter in order to control the expression of the reporter gene.

The reporter gene/protein is the most universal component in a whole-cell
biosensor. Reporters which are commonly used include LacZ/β-galactosidase, green
fluorescent proteins (GFP), and prokaryotic or eukaryotic luciferases. Owning to their
unique properties, these reporters can either lead to a color change in the solution or
generate light signals at certain wavelengths with or without the addition of substrates
[Gu, et al. 2004].
LacZ/β-galactosidase is an enzyme which catalyzes the cleavage of lactose

11

into galactose and glucose. It also cleave orthor-nitrophenyl-β-galactoside (ONPG) to
generate galactose and ortho-nitrophenol (Figure 1.6). The yellow color of
ortho-nitrophenol is utilized to quantify β-galactosidase. By measuring the time it
takes for a reaction to change color, expression level of β-galactosidase can be
evaluated.

Cleavage

of

other

substrates

such

as

methylumbelliferyl-β-D-galactopyranoside (MUG) yields fluorescent product, which
has also been utilized for the development of β-galactosidase quantification methods
[Daunert, et al. 2000].

Figure 1.6. β-galactosidase catalyzes the cleavage of o-nitrophenyl-β-galactoside to generate a
galactose and a yellow product, o-nitrophenol.

GFP was first isolated from the jellyfish, Aequoria victoria. GFP and its
homologs isolated from other marine creatures have been utilized as fluorescent
markers for labeling purposes [Chudakov, et al. 2010]. GFP absorbs light at ~480 nm
and emits green fluorescence at ~510 nm. The excitation and emission wavelength
may undergo blue- or red-shift by the influence of specific amino acids in the
environment [Chudakov, et al. 2010]. By measuring the intensity of fluorescence
emitted, the amount of expressed GFP could be quantified, which reflects the quantity
of target analytes.
Luciferases were discovered and isolated from both prokaryotic cells such as
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bacteria and eukaryotic cells such as firefly [Wilson and Hastings, 1998]. Their
working mechanisms are slightly different. In bacteria, the continuous emission of
bioluminescence requires five genes within the lux operon, luxCDABE. When
substrates are added to the medium, only two genes, luxA and luxB, are required for
light emission. Proteins LuxA and LuxB form a heterodimer which can catalyze the
oxidation of their substrates, long-chain aldehydes, to fatty acids. This reaction
involves the formation of an unstable high-energy bond and its breakage yields a blue
light at around 490 nm. Proteins LuxC, LuxD and LuxE catalyze the formation of
fatty aldehydes. Theses aldehydes will then serve as substrates for LuxA and LuxB to
emit bioluminescence. In the presence of these three additional proteins (LuxC, LuxD
and LuxE), there is no need for adding fatty aldehyde substrates. Firefly luciferase
utilizes another type of working mechanism that is far more complicated than bacteria
luciferase. It has been found that firefly luciferase is able to catalyze reactions to
produce an unstable intermediate which soon degrades and leads to the emission of
light (~550-570 nm) [Hastings, 1996]. The structure of substrates for firefly luciferase
is also more complex than substrates for bacteria luciferase. In terms of application,
both bacteria luciferases and firefly luciferase have been used in different biosensing
systems [Taurianen, et al. 1998].

A typical inducible expression whole-cell sensing system for the detection of
OH-PCBs is shown in Figure 1.7. A plasmid containing hbpR-PhbpC-luxAB fusion as
well as an ampicillin selectable marker was transformed into E. coli strain. hbpR gene
codes for a regulatory protein, HbpR; PhbpC is the promoter for hbpC gene while
luxAB codes for bacteria luciferase. hbpC gene belongs to a group of genes called hbp
genes. The hbp genes were found from Pseudomonas azelaica strain HBP1, coding
for enzymes catalyzing OH-PCB degradation. With these genes, HPB1 strain can
metabolize and live on OH-PCBs as its main carbon source. The hpb gene cluster
consists of three open reading frames, hbpC, hbpA and hbpD. And the expression of
these genes is under the control of two promoters, PhbpC and PhbpA and regulated by
one protein, HbpR. On Pseudomonas azelaica chromosome, HbpR is located
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upstream of PhbpC to control the expression of downstream genes. In the absence of
OH-PCBs, HbpR binds with PhbpC and prevents the expression of hbpC. The binding
of OH-PCBs leads to a conformational change in HbpR, which triggered the release
of HbpR from PhbpC. The release of PhbpC enables the production of HbpC to work on
metabolizing OH-PCBs.

This sensing and response mechanism is employed in the design of a
biosensing system. Instead of hbpC gene, luxAB was fused downstream of PhbpC. The
release of PhbpC thus activates the transcription of luxAB, producing bacteria
luciferase. With the addition of the substrate n-decanal, the intensity of
bioluminescence generated indicates the expression level of luciferase, which in turn
reflects the concentration of inducer target compounds. Therefore, the light intensity
is directly correlated with OH-PCB concentration [Turner, et al. 2007].

Figure 1. 7. Inducible expression whole-cell sensing system. A reporter gene is placed under the
transcriptional promoter that is under the control of a regulator. (a) In the absence of analytes, the
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regulator binds the promoter and prevents expression of the reporter gene. (b) After the addition of
analytes, the regulator will bind with analytes instead of promoter. The release of promoter leads
to the expression of the reporter gene. And reporter protein will generate signals with the addition
of specific substrates.

1.5 Efflux system of alien chemicals in Gram-negative bacteria

Bacteria have adapted to thrive at many harsh conditions including in the
presence of high concentrations of toxic metalloids such as arsenic and antimony,
toxic metals such as chromium, lead and mercury, as well as harmful organic
compounds. To survive under these conditions, the resourceful bacteria have evolved
intricate mechanisms to reduce the impact of the toxins on their own metabolism. A
well-studied example of the adaptive evolution of microbes is the emerging and
prevalence of antimicrobial resistance in microbial pathogens infecting human and
domestic animals. Due to years of intensive usage of antibiotic in the treatments of
infections, bacteria exposed to antibiotics have developed several types of defense
mechanisms. Some bacteria produce specific enzymes such as β-lactamases to break
down or deactivate antibiotics. Bacteria become resistant to one drug or one type of
drugs through this mechanism. Some bacteria alter their cellular components targeted
by antibiotics through mutations or enzymatic modifications. The affinities between
antibiotics and their targets are therefore reduced. The third mechanism involves
multidrug resistance efflux pumps. Bacteria can flush drugs out of the cell through the
multidrug efflux pumps located on their membranes, and thus reduced the
intra-cellular concentration of antibiotics to a sub-toxic level that is not lethal to the
microbe.

Multidrug efflux pumps are encoded in the genomes of all bacteria. We
speculate that these pumps might play a role in microorganisms used at the
bioremediation site of PCBs. An analysis of E. coli genome reveals the existence of
37 open reading frames encoding putative drug transporters [Nashino, 2001]. Nishino
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et al. have shown that 20 out of them are clearly involved in drug resistance, but not
all 20 drug exporters are constitutively expressed. These identified drug efflux pumps
were also found to be able to recognize novel drugs which are still under development
by pharmaceutical companies [Nashino, et al. 2009].

Membrane transporters play an essential role in maintaining functionality of
living cells. Other than protecting bacteria in a toxic environment, they keep ionic
balances in between cytoplasm, periplasm and the outside environment by
transporting ions such as Na+ and K+ across cell membranes. They also take up
nutrients and exchange cellular communication molecules with the environment.
There are more than 500 families of transporter systems belonging to several
superfamilies, including the APT binding cassette (ABC) superfamily, the major
facilitator superfamily (MFS), the resistance/nodulation/division (RND) superfamily,
the amino acid-polyamine-organocation (APC) superfamily, and the voltage-gated ion
channel (VIC) superfamily [Paulsen, 2003; Ren, et al. 2007]. Drug transporters in E.
coli belong to five families, including MacAB from ABC superfamily, AcrAB from
RND superfamily, EmrAB from MFS superfamily, Mdtk from multidrug and toxic
compound exporters (MATE) family and EmrE from the small multidrug resistance
(SMR) family. They work synergistically to build up the drug resistance of E. coli
strains [Saier, et al. 2000; Pos, 2009].

Multidrug pump systems in E. coli have been studies extensively. Individual
gene was knocked out separately in order to determine the contribution of each pump
system in the drug resistant mechanism by Sulavid et al. It turned out that among all
the pump systems, AcrA-AcrB-TolC system is the dominant and constitutively
expressed one while others are weakly expressed under normal conditions [Sulavik, et
al. 2001].

AcrA-AcrB-TolC is a tripartite protein complex with the structure shown in
Figure 1.8. The AcrAB-TolC system has homologs in almost every gram-negative
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bacterium strain. The major component AcrB is the multidrug efflux pump, belonging
to the RND superfamily. Periplasmic fusion protein AcrA is the adaptor between AcrB
and TolC and it contributes to the formation of a stable interaction between AcrB and
TolC. TolC is a β-barrel protein located in the outer membrane. It functions as a
channel to allow drugs passing through to the outside environment. TolC can also be
employed by another pump system: EmrAB, to form another tripartite complex,
EmrAB-TolC. The organization of AcrAB-TolC system provides effective protection
for Gram-negative bacteria since once drugs are extruded to the outside environment,
they have to traverse the outer membrane barrier again in order to reenter the cells
[Nikaido and Takatsuka, 2009].
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Figure 1.8. AcrAB-TolC transmembrane complex located in Gram-negative bacteria. TolC (pink)
is the outer membrane channel. AcrB (green) locates at the interface of inner membrane and
periplasm. AcrA (brown) works as an adapter between AcrB and TolC.
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1.6 Protein AcrB

As the inner membrane component of the complex which provides a pathway
for drug transport, AcrB became the focus of many studies and has been well
characterized. AcrB exists as a trimer. In 2002, the crystal structure of AcrB was
solved by Murakami et al., which reveals that AcrB is an asymmetric homotrimer.
Each of the AcrB monomers is made up of 1049 amino acids. Its N-terminal half
shows sequence homology and structural similarity with the C-terminal half [Seeger,
et al. 2008]. The transmembrane domain of AcrB is made up of twelve α-helices. The
periplasmic part of AcrB contains a TolC docking and a pore forming domain. A
central cavity is formed in the center of AcrB trimer structure where substrates enter
and be captured. The co-crystallization of AcrB and its substrates shows that these
compounds are inside the central cavity. A loop structure located at the top of TolC
docking domain from each monomer extends into the adjacent monomer and this
interaction stabilizes the AcrB trimer structure. A vestibule area was found at the
interface of transmembrane domain and periplasm domain and was suggested to be
the first site where drugs enter to reach the central cavity (Figure 1.9).

AcrB employs a conformational cycling mechanism to export substrates,
resembling that of a peristaltic pump. At any specific time, three monomers exhibit
distinct conformations: loose (L), tight (T) and open (O). Each monomer rotates
through these three conformations in turn (Figure 1.10). At the loose state, substrates
enter the binding site. Then the monomer change conformation to the tight state in
order to capture the substrate plus an H+ ion. Finally, it will change conformation
again to the open state and pump substrates through the TolC channel while at the
same time losing the H+. Through this mechanism, the transmembrane proton gradient
is exploited to drive the conformational change that enabled the efflux of drugs
[Seeger, et al. 2008; Pos, 2009].
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Figure 1.9. AcrB monomer structure. AcrB monomer contains a transmembrane domain, a pore
forming domain, and the TolC docking domain. A loop structure extends into another AcrB
monomer to stabilize AcrB trimer.

Figure 1.10. Schematic representation of the AcrB conformational cycling transport mechanism.
AcrB monomers are labeled different colors: orange, green and purple. The different geometric
forms reflect conformational state loose (triangle), tight (rectangle), and open (circle). At Loose
state, a substrate (indole) is fusing into AcrB. With a conformation change to tight state, AcrB
exhibits high binding affinity to the substrate in the hydrophobic binding pocket. And finally, the
substrate is released towards TolC following AcrB conformation changing to open state.
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One characteristic of AcrB, similar with other multidrug efflux pumps, is that
it has a wide range of substrates, including antibiotics (erythromycin, novobiocin,
tetracycline, β-lactams, etc.), dyes (ethidium bromide, rhodamine 6G, crystal violet,
Nile red, etc.), detergents (sodium dodecyl sulfate, Triton X-100, etc.), bile salts
(cholate), and small organic molecules (hexane, cyclohexane, etc.) [Elkins and
Nikaido, 2002; Takatsuka, et al. 2010]. These substrates can be charged or neutral,
and differ dramatically in their molecular weights. However, these substrates show
one thing in common: they all contain a large hydrophobic component. Accordingly,
in terms of property, they are either hydrophobic or amphiphilic. Some examples of
established AcrB substrates are shown in Figure 1.11. It was found that AcrB
recognizes and picks up its substrates from the interface of inner membrane and
periplasm where these lipophilic or amphiphilic molecules accumulate [Nikaido and
Takatsuka, 2009]. This observation prompts us to examine the potential roles played
by drug efflux pumps such as AcrB in the retention and efflux of PCBs and OH-PCBs,
as such activities will affect the effectiveness of bioremediation of these compounds
using microbes.
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Figure 1.11. Structures of different substrates of AcrB

22

1.7 Summary

As discussed above, PCBs and its metabolites OH-PCBs are hazardous
environmental pollutants that have an adverse effect on the health of both human
beings and wildlife. In this thesis research, I investigated the ability of a major
multidrug efflux transporter protein, AcrB, to efflux PCBs and OH-PCBs from the
cell. A wild-type E. coli strain (BW25113) and its corresponding acrB gene knock-out
strain (BW25113∆acrB) were utilized to elucidate the potential role of AcrB in the
uptake and retention of PCBs and OH-PCBs. PCB and OH-PCB toxicity assays were
conducted using both strains to analyze the differences in their susceptibility. The
accumulation of PCBs and OH-PCBs in the cells were first measured by GC/MS.
Experimental results revealed that more of these compounds accumulated in the acrB
gene knockout strain than the wild-type strain. I further confirmed this result using a
genetically engineered

whole-cell

biosensing system

to

analyze

OH-PCB

concentrations in bacterial cytoplasm. A plasmid containing HbpR-PhbpC-luxAB fusion
DNA was transformed into BW25113 and BW25113∆acrB. In the presence of
OH-PCBs, the regulatory protein HbpR binds to the analyte instead of the promoter
and triggers the expression of luciferase coded by luxAB gene. By measuring the
bioluminescence intensity, the intracellular concentrations of OH-PCB in the two
strains were compared. When the same concentration of OH-PCBs were added in cell
cultures, higher intensity of bioluminescence had been recorded in BW25113∆acrB
than in BW25113, indicating higher concentrations of OH-PCBs are present in the
cytoplasm of BW25113∆acrB. My results suggest that PCBs and OH-PCBs are likely
substrates for AcrB. The efflux activities of membrane transporters should be
considered while designing bioremediation experiments.
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Chapter II: Materials and Methods

2.1 Reagents

Polychlorinated biphenyls (names and correlated structures shown in Figure
2.1) including PCB77, PCB104, PCB118, PCB126, PCB153, PCB166, PCB65 and
PCB209, monohydroxylated polychlorinated biphenyls (names and correlated
structures shown in Figure 2.2) including HPCB1001, HPCB2006, HPCB3001,
HPCB4002

and

HPCB5001,

pyrene

N,O-Bis(trimethylsilyl)trifluoroacetamide

with

D-10

(C16D10)

trimethylchlorosilane

and

silylating

reagent were purchased from AccuStandard Inc. (New Haven, CT). Dimethyl
sulfoxide, sodium hydroxide, potassium hydroxide, ethylenediaminetetraacetic acid
(EDTA), calcium dichloride dihydrate and kanamycin sulfate were purchased from
BioWorld Inc. (Atlanta, GA). Hexane, isooctane, methylene chloride, hydrochloric
acid and ferrous chloride were purchased from Fisher Scientific (Fair Lawn, NJ).
Decanal, erythromycin, novobiocin, ampicillin, D-(+)-glucose, ammonium chloride,
zinc sulfate heptahydrate, manganese sulfate monohydrate, copper sulfate
pentahydrate, cobalt chloride, sodium borate, Luria-Bertani Broth, trypton, yeast
extract, biotin, nicotinic acid and thiamine hydrochloride were purchased from
Sigma-Aldrich (St. Louis, MO). Nitrilotriacetic acid was purchased from Fluka
(Switzerland). Sulfuric acid and magnesium sulfate were purchased from EMD
Chemicals (Gibbstown, NJ). All chemicals were reagents grade or better and were
used as received.

24

Figure 2.1. Names and correlated structures of PCBs used in this study.

Figure 2.2. Names and correlated structures of OH-PCBs used in this study.

2.2 Bacterial strains and plasmids

Wild-type Escherichia coli strain BW25113 and the corresponding acrB gene
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knockout strain BW25113∆acrB (in which acrB gene was replaced by a kanamycin
selectable marker) were obtained from Yale Coli Genetic Stock Center. E. coli strain
DH10 harboring plasmid pHYBY109 was a kind gift from Dr. Sylvia Daunert. The
plasmid pHYBY109 carries hbpR operon that confers resistance to OH-PCBs and
LuxAB reporter gene coding for the bacteria luciferase as well as an ampicillin
selectable marker. Plasmid pHYBY109 was transformed into BW25113 and
BW25113∆acrB. All bacteria strains were preserved as glycerol stocks (15% glycerol)
and kept at -80 ºC.

2.3 Toxicity assay

PCB stock solutions were prepared by dissolving individual PCBs in hexane at
the concentration of 100 μg/mL. OH-PCB stock solutions were prepared by
dissolving individual OH-PCBs in DMSO at the concentration of 10-2 M. Stock
solutions were kept at 4 ºC. The stock solution was freshly diluted to the desired
concentration right before each experiment.
3 mL of overnight culture in LB were prepared for all strains. For
BW25113∆acrB, 50 μg/mL kanamycin was added to the culture to prevent cross
contamination. The cultures were incubated overnight at 37 oC on an orbital shaker
(New Brunswick Scientific Excella E24 Incubator Shaker, New Brunswick, Edison,
NJ) at 250 rpm. The next morning, the overnight cultures were diluted 1000 times in
fresh LB medium. In parallel, PCBs or OH-PCBs were added into wells of sterile
24-well cell culture plates (BioTek Inc., Winooski, VT). The solvent was allowed to
evaporate. 800 μL of the diluted cell culture was then added into each well. The plates
were shaken on a plate shaker at 37 oC, 220 rpm for 6 hours. The optical density of
cells at 600 nm in each well was then measured using the Epoch multi-volume
spectrometer system (BioTek Inc., Winooski, VT).

2.4 Accumulation assay
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2.4.1 Cell preparation

An overnight culture of each strain was prepared by adding 50 μL fresh
culture to 50 mL LB medium. The culture for BW25113∆acrB strain contained 50
μg/mL kanamycin. Flasks were shaken at 37 oC on an orbital shaker at 250 rpm
overnight. PCB and OH-PCBs stock solutions were added to autoclaved 250 mL
Pyrex flasks and solvents were allowed to evaporate. Next, 100 mL LB medium and
20 mL overnight culture were transferred into the flask containing either PCBs or
OH-PCBs. The flasks were incubated at 37 oC in the orbital shaker at 220 rpm. 10 mL
cultures were withdrawn after 1, 3, 5, 10, and 24 hours of incubation and processed as
described below.

2.4.2 Extraction and treatment

10 mL cell culture was centrifuged using a Beckman Coulter Allegra 25R
Centrifuge (Brea, CA) at 5000 rpm for 10 minutes. Cell pellets were resuspended in
1.5 mL PBS buffer (one liter PBS buffer containing: 1.42 g of Na2HPO4, 8.0 g of
NaCl, 0.27 g of KH2PO4 and 0.20 g of KCl, with pH adjusted to 7.4). The solutions
were then transferred into pre-weighed Eppendorf tubes and centrifuged at 5000 rpm
for 5 min. The tubes were decanted to remove the supernatant. The residual liquid was
absorbed by Kimwipe tissue paper. Cell weights were measured from the difference
between the weight of Eppendorf tubes with cell pellets and the weight of the empty
tubes.

Cells were then resuspended in 2 mL deionized water and immediately
transferred to 5 mL VWR glass vials. After the addition of the recovery standard
solution (100 μL PCB 166, 1.0 μg/mL for PCB accumulation assay or 300 μL
HPCB1001, 2.0 μg/mL, for OH-PCB accumulation assay), cells were lysed using a
Fisher Scientific sonicator (Hanover Park, IL). PCBs and OH-PCBs were then
extracted by votex mixing the cell lysate with 2 mL of hexane for 20 min and shaken
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on an orbital shaker at room temperature, 100 rpm for another 10 min to achieve
higher extraction efficiency. Organic phase was transferred to another 5 mL glass vial.
1 mL concentrated H2SO4 was added to remove lipids from the organic phase. After
vortexed for 1 min, the sample was left overnight to allow the separation of the two
phases. The next morning, the organic phase was withdrawn and concentrated to 100
μL under a gentle stream of nitrogen.

For PCB accumulation assay, the concentrated samples were transferred using
a glass syringe to 1.5 mL Agilent GC/MS glass vials (with glass insert). 10 μL of
internal standard PCB209 (1 μg/mL) was spiked into each sample before it was
injected into GC/MS. An internal standard (ISTD) is a compound added to a sample
in known concentration to facilitate the qualitative identification and/or quantitative
determination of the sample components [IUPAC, 1997].

For OH-PCB accumulation assay, after the concentration of the sample, 100
μL of silylating reagents (BSTFA: TMCS= 99:1, v/v) were added. The vials were then
tightly capped and placed in a temperature controller (PolyScience Inc., Niles, IL) at
60 oC for 40 min to allow the derivatization of hydroxyl groups in OH-PCBs. After
derivatization, silylating reagents were evaporated. The dried solute was re-dissolved
in 100 μL hexane. The solution was transferred into 1.5 mL Agilent GC/MS glass vial
(with glass insert). 10 μL ISTD pyrene-d10 (1 μg/mL) was added as ISTD before the
GC/MS analysis.

2.4.3 GC/MS operation

PCBs and OH-PCBs were analyzed using an Agilent 6890 Gas
Chromatograph coupled with Agilent 5975 Inert Mass Selective Detector (Agilent,
Santa Clara, CA). GC/MS conditions can be found in Table 2.1.
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Capillary column: HP-5MS 5% Phenyl-Methyl Siloxane Column, Agilent
Length: 30m; Internal Diameter: 0.25 mm; Film Thickness: 0.25 μm
Carrier gas: Ultra-Pure Helium, 1.2 ml/min
Injection mode: Splitless (Purge on at 0.75 min)
Injection port temperature: 250 oC
Oven temperature program:
60 (hold 1 min, 40 oC /min)
200 oC (4 oC /min)

200 oC ;

280 oC (hold for 5.5 min)
Run time: 30 min

✽ Inject hexane/methylene chloride between runs to reduce carry-over problem
Table 2.1 GC/MS conditions applied in this study

Calibration curves for different PCBs were established with seven
concentration points for each species in the range of 0.05- 3.5 μg/mL (0.05, 0.1, 0.2,
0.5, 1, 2, 3.5 μg/mL), each containing 0.1 μg/mL of ISTD (PCB209). Calibration
curves for OH-PCBs were established with seven concentration points within the
range of 0.1-10 μg/mL (0.2, 0.5, 1, 2, 5, 10 μg/mL), each containing 0.1 μg/mL of
ISTD (pyrene-d10).

The ratio of peak for each compound to that of the ISTD was used for
quantification.

2.5 Bioluminescence assay

2.5.1 Preparation of cells harboring pHYBY109

Plasmid pHYBY109 was transformed into BW25113 and BW25113∆acrB
using the heat shock method [Froger, et al. 2007]. Overnight cultures for both
BW25113 and BW25113∆acrB harboring plasmid pHYBY109 were prepared one
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day before testing. For BW25113-pHYBY109, 50 mL LB medium containing
ampicillin (100 μg/mL) was added in a 250 mL flask followed by the addition of 50
μL fresh cell culture. The culture for BW25113∆acrB-pHYBY109 was made by
adding 50 μL fresh cell culture to 50 ml LB medium containing kanamycin (50 μg/mL)
and ampicillin (100 μg/mL). Flasks were kept at 37 oC on an orbital shaker at 250 rpm
overnight.

For the luciferase induction assay, 3 mL overnight cultures was transferred
into each flask containing 50 mL mineral medium (MM) [Jaspers, et al. 2001].
OH-PCB stock solutions were then added to the desired concentration. All tests were
prepared in triplicate. These flasks were placed at 30 oC on an orbital shaker at 225
rpm for 5 h incubation period.

Mineral medium (per liter) contains: 1.00 g of NH4Cl, 3.49 g of
Na2HPO4·2H2O, 2.77 g of KH2PO4, 2.0 mL a vitamin solution, 20 mL Hunter’s
vitamin-free mineral base, 0.01% trypton, 0.005% yeast extracts, and 10 mM
D-(+)-glucose,

adjusted to pH 6.8. The vitamin solution (per 100 mL) contained the

following: 0.5 of mg biotin, 50 mg of nicotinic acid, and 25 mg of thiamine
hydrochloride. Hunter’s vitamin-free mineral base (per liter) was prepared by mixing
10 g of nitrilotriacetic acid, 6.0 g of KOH, 14.5 g of MgSO4·7H2O, 3.33 g of
CaCl2·2H2O, 9.74 mg of (NH4)6MoO24·4H2O, 99 mg of FeSO4·7H2O and 50 ml
Metal 44 Solution. The Metal 44 Solution (per 100 ml) contains 387 mg of
Na4EDTA·4H2O, 1.10 g of ZnSO4·7H2O, 914 mg of FeSO4·7H2O, 154 mg of
MnSO4·H2O, 39.2 mg of CuSO4·5H2O, 24.8 mg of Co(NO3)2·6H2O, 17.7 mg of
NaB4O7·19H2O and it was neutralized with H2SO4. MM was sterilized and stored at 4
o

C before use.

2.5.2 Bioluminescence detection

After the 5 hours incubation, 50 mL cell culture was centrifuged at 5000 rpm
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for 10 min. Cell pellet was resuspended in 3 mL PBS buffer. For the final assay, 0.3
mL of cell was transferred into a far UV quartz cuvette. Following the addition of 30
μL n-decanal (50 mM in 1:1 ethanol/H2O), bioluminescence was immediately
measured using a PerkinElmer LS55 Fluorescence Spectrometer (Waltham, MA) set
at bioluminescence measurements. Light output was integrated from 5 s to 30 s and
the total light signal was expressed as relative light unit (RLU).
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Chapter III: Results and Discussion

3.1 PCBs and OH-PCBs used in this study

Five PCBs were selected as model compounds in this study, including PCB77,
PCB104, PCB118, PCB126, and PCB153. Different levels of chlorination are present
in the chosen PCBs, from four chlorine substitutions to six chlorine substitutions.
Three of the PCBs (PCB77, PCB118, and PCB126) are co-planar congeners while the
remaining two (PCB104 and PCB153) are non-planar congeners. PCBs were kept at 4
o

C upon received and dissolved in hexane before performing tests.

Although there are 837 possible monohydroxylated-PCB congeners, only
limited

numbers

of

these

compounds

are

commercially

available.

Four

monohydroxylated-PCBs were selected as target compounds in this study, including
HPCB2006, HPCB3001, HPCB4002, and HPCB5001. All selected OH-PCBs contain
one hydroxyl group substitution on carbon position 2 of the biphenyl structure.
Different levels of chlorination are present in chosen OH-PCBs, from two chlorine
substitutions in HPCB2006 to five chlorine substitutions in HPCB5003. The chosen
OH-PCBs have been included in the study of a whole-cell biosensing system (Turner
et al., 2007). OH-PCBs were kept at 4 oC and dissolved in DMSO before performing
tests.

3.2 PCB toxicity on E. coli

Toxicity of chosen PCBs were determined in both wild-type E. coli strain
BW25113 and an acrB gene knockout strain BW25113∆acrB. PCBs were applied as a
mixture of all five PCBs and the total PCB concentration in cell cultures ranged from
0.8 to 12.8 μg/mL. Optical densities of cells at 600 nm were measured after 6 hours of
incubation (Figure 3.1).
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Figure 3.1. Toxicity assay for PCB mixture in BW25113 (orange) and BW25113∆acrB (blue). AU,
arbitrary unit.

PCBs showed no toxicity at levels examined in both BW25113 and
BW25113∆acrB, presumably due to the low solubility and bioavailability of these
hydrophobic compounds.

3.3 OH-PCB toxicity on E. coli

Toxicity of chosen OH-PCBs was investigated in both BW25113 and
BW25113∆acrB. Individual OH-PCB was tested separately in order to reveal the
differences in their toxic effects. Different concentrations of OH-PCBs in the range
from 0.4 to 6.4 μg/mL were present in cell cultures. Optical densities of cells at 600
nm were measured after 6 hours incubation. Testing results for each OH-PCB along
with the negative control are shown in Figure 3.2. to Figure 3.5. Data are normalized
to the optical densities of the cell culture in the absence of OH-PCBs.
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Figure 3. 2. Toxicity assay for HPCB2006 in BW25113 (orange) and BW25113∆acrB (blue). AU,
arbitrary unit.

Figure 3. 3. Toxicity assay for HPCB3001 in BW25113 (orange) and BW25113∆acrB (blue). AU,
arbitrary unit.
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Figure 3. 4. Toxicity assay for HPCB4002 in BW25113 (orange) and BW25113∆acrB (blue). AU,
arbitrary unit.

Figure 3. 5. Toxicity assay for HPCB5001 in BW25113 (orange) and BW25113∆acrB (blue). AU,
arbitrary unit.
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Different levels of toxicity were observed for different OH-PCBs as well as
for the two E. coli strains. Among the four OH-PCBs tested, the levels of toxicity
decreases from HPCB5001 to HPCB2006, and then to HPCB3001 and HPCB4002.
BW25113 exhibits higher tolerance to OH-PCBs than BW25113∆acrB, indicating the
significance of protein AcrB in conferring bacteria resistance toward OH-PCBs.
Knocking out acrB gene directly leads to the lack of protein AcrB in the cell, through
which BW25113∆acrB strain loses its major multidrug efflux pump. As a result,
OH-PCBs accumulate in cells and cause lethal effects to the cells.

3.4 PCB and OH-PCB accumulation assay in E. coli

3.4.1 Establishment of GC/MS method

All seven PCBs could be completely separated on the GC/MS chromatogram
within 30 min under applied conditions. Each species displayed a single peak with a
nice peak shape. A chromatogram of a sample containing mixed PCBs with each peak
identified is shown in Figure 3.6. Target PCB identifications were confirmed by mass
spectra as shown in Figure 3.7. The molecular ions [M+] of eight PCBs were 498, 292,
292, 326, 326, 326, 360, and 360, for PCB209, PCB77, PCB65, PCB104, PCB118,
PCB126, PCB153, and PCB166, respectively. The highest abundant fragment ion was
utilized for quantification and analysis.
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Figure 3.6 Gas chromatogram for model PCBs. AU, arbitrary unit.
Peak identity: 1. PCB65; 2. PCB104; 3. PCB77; 4. PCB118; 5. PCB153; 6. PCB126; 7. PCB166;
8. PCB209 (ISTD).
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A.

B.
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C.

D.
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E.

Figure 3.7 Mass spectra for five target PCBs: PCB77 (A), PCB104 (B), PCB118 (C), PCB126 (D),
and PCB153 (E). The molecular ion [M+] for quantification is marked as bold black numbers on
each plot.

In this study, PCB166 were used as PCB recovery standards. Extraction
recoveries for all PCBs at different incubation times ranged from 14.6% to 62.7%.
Standard calibration curves for each PCB were shown in Figure 3.8.
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B.
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Figure 3.8. Standard calibration curves and coefficient for all PCBs: PCB77 (A), PCB104 (B),
PCB118 (C), PCB126 (D), PCB153 (E), and PCB166 (F). AU, arbitrary unit.

3.4.2 Accumulation of PCBs in wild-type and acrB knockout E. coli

As described in Chapter II, BW25113 and BW25113∆acrB cell cultures were
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incubated in the presence of PCBs. At specified time, small portions of the cell culture
were taken and processed to determine the PCB contents in the cell pellet. The
quantity of PCB was normalized to the weight of the cell pellet. The accumulation
data determined over time are shown in Figure 3.9.

A.
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Figure 3.9 PCB accumulation assay in BW25113 (orange) and BW25113∆acrB (blue). The
concentrations of PCB in cell pellets collected at 1, 3, 5, 10, and 24 h were determined and
normalized over the cell weight.

Two observations were made through the accumulation studies: First, the
46

accumulation of PCB in cells did not increase over time. For BW25113, the level of
PCBs remained stable within the error range over the time period collected. For
BW25113∆acrB, the accumulation level reached the maximum value within one hour,
and then decreased slightly over time. Second, comparing the one hour accumulation
data, higher concentration of PCBs accumulated in BW25113∆acrB than in BW25113.
This observation is consistent with our speculation that PCBs are substrates of AcrB.
BW25113∆acrB lacked functional AcrB, and therefore was less effective in pumping
out PCBs.

While the same initial concentrations were used, different PCBs displayed
different accumulation levels. The difference in accumulation could result from two
factors: first, the differences in the AcrB efflux efficiency of various PCBs; second,
the difference in the intrinsic solubility and bioavailability of the PCBs. The
differences in the AcrB efflux efficiency are reflected from the differences in the PCB
accumulation amounts in BW25113 and BW25113∆acrB. Through comparing, after 1
hour of incubation, the accumulation levels of all five PCBs in BW25113 are
approximately 44-50% of the level in BW25113∆acrB, indicating AcrB efflux the five
PCBs with a similar efficiency (Table 3.1).

To compare the intrinsic solubility and bioavailability of the PCBs, we
compared the accumulation in the BW25113∆acrB strain (Figure 3.10). While the
same concentration of PCBs existed in the cell culture, distinct accumulation levels
were observed. Among all five PCBs, PCB126 has the highest while PCB153 has the
lowest bioavailability. The bioavailability of PCBs is correlated with their structures.
In this study, PCB126 and PCB77 have co-planar structures which lead to their
relatively high water solubility and bioavailability, while PCB104, PCB118, and
PCB153 have non-planar structures and thus low solubility and bioavailability.
Therefore, distinguished accumulation levels of PCBs are likely due to differences in
bioavailability of target PCBs.
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Table 3.1 PCB accumulation in BW25113 and BW25113∆acrB with one hour incubation.
BW25113
(PCB/Cell Weight, μg/g)

BW25113∆acrB
(PCB/Cell Weight, μg/g)

WT / ∆acrB
(%)

PCB77

99.96

222.32

44.90

PCB104

64.73

131.41

49.26

PCB118

69.98

142.36

49.17

PCB126

106.90

236.80

45.14

PCB153

49.81

110.17

45.24

Figure 3.10. Accumulation of five PCBs in BW25113∆acrB with one hour incubation. PCB
amounts are normalized to cell weights.

One question remains to be answered, why the PCB level in BW25113∆acrB
decreased over time. After 24 hours of incubation, the concentration of PCB in
BW25113∆acrB decreased to a level comparable to the level in wild-type E. coli. On
the contrary, the PCB level in the wild-type strain BW25113 remained at a constant
level. We speculate that the presence of PCBs might have triggered the producing of
48

other efflux pumps which are coded in the bacteria genome.

3.4.3 Accumulation of OH-PCBs in wild-type and acrB knockout E. coli

The presence of the -OH group in monohydroxylated PCBs increases the
difficulty in using GC for analysis, since it drastically reduced the volatility of the
compound. Therefore, derivatization is necessary to overcome the low volatility of
OH-PCBs. I tested two derivatization approaches, methylation and silylation. I found
silylation was superior, because the reaction occurs in milder conditions than
methylation, with shorter incubation time and relatively low temperature. Silylation
procedure with BSTFA/TMCS reagent (at 60℃ for 40 min) for derivatization [Shi et
al, 2009] is applied in this study. Silylating reaction of HPCB2006 is shown in Figure
3.11.

GC chromatograms were collected using silylated OH-PCBs. All four
compounds were completely resolved as shown in Figure 3.12. Peaks were identified
with standards as well as known spectra from the compound library. Molecular ions
[M+] detected in each of OH-PCB silylation products were at 275, 310, 346, 380, and
414, for HPCB1001, HPCB2006, HPCB3001, HPCB4002, and HPCB5001,
respectively. An ion with the mass to charge ratio of 93 was selected for quantifying
OH-PCBs. As shown in Figure 3.13, mass spectra for OH-PCB silylation products
were obtained as well.

In this study, pyrene-d10 was chosen as ISTD. HPCB1001 was used as
recovery standard for OH-PCBs. The extraction recovery for all four OH-PCBs is in
the range from 13.4% to 95.6%. The standard calibration curves for the OH-PCBs
used in this study are shown in Figure 3.14.
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Figure 3.11. HPCB2006 silylating reaction equation.
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Figure 3.12. Gas chromatogram of a sample containing a mixture of silylated OH-PCBs. AU,
arbitrary

unit.

Peak

identity:

1.

HPCB1001-Si(CH3)3;

2.

HPCB3001-Si(CH3)3 ;

HPCB2006-Si(CH3)3 ; 4. HPCB4002-Si(CH3)3 ; 5. pyrene-d10 (ISTD); 6. HPCB5001-Si(CH3)3.
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Figure 3.13. Mass spectra of four OH-PCB silylation products: HPCB2006 (A), HPCB3001 (B),
HPCB4002 (C), and HPCB5001 (D). Chemical structures of targets are shown in the plots. Mass
ion used for quantification is marked with a bold black number on each plot.
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Figure 3.14. Standard calibration curves and coefficient of deviation from GC/MS for all OH-PCB
silylation products: HPCB1001 (A), HPCB2006 (B), HPCB3001 (C), HPCB4002 (D), and
HPCB5001 (E). AU, arbitrary unit.

A mixture of four OH-PCBs was added to BW25113 and BW25113∆acrB to
mimic the real samples in which PCB metabolites are present in a mixture. Total
OH-PCB concentration in cell cultures reached 0.4 μg/mL (0.1 μg/mL of each
OH-PCB, respectively) and was controlled at equal to or less than 0.4 μg/mL in the
following tests. According to previous toxicity assays, OH-PCBs at these
concentrations did not have a significant toxic effect. Accumulation of individual
OH-PCB in cell strains was shown in Figure 3.15. Several observations were made.

First, there is a drastic difference in OH-PCB accumulation levels between
BW25113 and BW25113∆acrB. This result is consistent with previous observations
with PCBs. Again, it supports the hypothesis that OH-PCBs are AcrB substrate.
Second, in the wild-type strain BW25113, OH-PCB accumulation level maintained
relatively constant up to 24 hours of incubation. While in the gene knockout strain
BW25113∆acrB, the amount of PCB reduced with time. This observation is again
similar to previous experimental results obtained for the accumulation experiment of
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PCBs. Third, the efflux efficiencies of AcrB for different OH-PCBs were clearly
different, as revealed by the difference between the accumulation levels of each
OH-PCB in BW25113 and BW25113∆acrB (Table 3.2). Among four OH-PCBs,
HPCB4002 accumulated in BW25113∆acrB 12 fold more than that in BW25113,
suggesting high efflux efficiency of protein AcrB to transport HPCB4002. HPCB5001
accumulation amount in BW25113∆acrB was only 1.5 fold more than the level in
BW25113, which indicated that AcrB has relatively low efflux efficiency towards
HPCB5001. Bioavaialbility of different OH-PCBs is reflected from the accumulation
amount in BW25113∆acrB as shown in Figure 3.16. The accumulation level of
HPCB2006 which has a co-planar structure is 3 fold the amount of HPCB3001 and
HPCB4002, and 1.3 fold the amount of HPCB5001, suggesting its high bioavailability,
while the other three OH-PCBs have non-planar structure which directly leads to their
low bioavailability.

A.
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Figure 3.15. Accumulations of HPCB2006 (A), HPCB3001 (B), HPCB4002 (C), and HPCB5001
(D) in BW25113 (orange) and BW25113∆acrB (blue). OH-PCB accumulations in E. coli were
measured after 1, 3, 5, 10, and 24 h of incubation.

Table 3.2 OH-PCB accumulation in BW25113 and BW25113∆acrB after one hour
incubation
BW25113

BW25113∆acrB

(PCB/Cell Weight, μg/g)

(PCB/Cell Weight, μg/g)

WT / ∆acrB
(%)

HPCB2006

1.441

10.061

14.32

HPCB3001

0.911

3.487

26.12

HPCB4002

0.286

3.248

8.81

HPCB5001

4.671

6.933

67.37
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Figure 3.16. Accumulation of four OH-PCBs in BW25113∆acrB with one hour incubation.
OH-PCB amounts are normalized to cell weights.

To evaluate the effect of initial OH-PCB concentration on cellular
accumulations, we measured HPCB2006 accumulation after 1 hour of incubation at
three different concentrations, 0.1, 0.2, and 0.4 μg/mL. HPCB2006 accumulation in
BW25113 and BW25113∆acrB after 1, 3, 5, 10, and 24 h of incubation were
measured by GC/MS. As shown in Figure 3.17 and Figure 3.18, HPCB2006
accumulation level correlates positively with initial concentrations. When HPCB2006
concentration increases from 0.1 to 0.4 μg/mL, the accumulation in BW25113∆acrB
increases from 1.5 fold to 4 fold of that in BW25113 strain. The results further
confirm that protein AcrB works on extruding OH-PCBs. Additionally, the results
suggest that the AcrB pump efflux efficiency is dependent on the amount of toxic
compounds present. Moreover, OH-PCB accumulation decreases rapidly with time in
BW25113∆acrB as comparing Figure 3.17 and Figure 3.18. The decrease ratio is
dependent on the concentration of OH-PCBs. This observation is in agreement with
previous results on PCBs and again we speculate that the presence of toxic
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compounds such as OH-PCBs triggers the self-defense system in bacteria: other
efflux pumps are therefore being expressed. The response, however, takes certain
amount of time to be reflected from the compound accumulation results.

Figure 3.17. HPCB2006 accumulation in BW25113 (Orange) and BW25113∆acrB (Blue) with 1
hour of incubation in response to initial concentration applied.
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Figure 3.18. HPCB2006 accumulation in BW25113 (Orange) and BW25113∆acrB (Blue) with 10
hours of incubation in response to initial concentration applied.

3.5 Bioluminescence assay

The hbp genes enable P. azelaica to degrade hydroxylated biphenyls and use
them as sole carbon sources. The mechanism involved has been well characterized
[Kohler, et al. 1988]. A group of plasmids containing different hbp genes as well as
promoters were constructed by Jaspers et al to further explore the characteristics of
the promoter genes [Jaspers, 2000]. They found a transcription activator hbpR protein
and two promoters that control the expression of hbp genes. Later, a plasmid
(pHYBY109) containing hbpR-PhbpC-luxAB fusion was created and transformed into
E. coli for the studying of PhbpC promoter activity [Jaspers, 2001]. Upon the addition
of OH-PCBs, increase of bioluminescent signals was detected, suggesting the binding
of OH-PCBs to HbpR leads to direct activation of the promoter PhbpC.

In our study, the plasmid pHYBY109 was transformed to both wild-type E.
coli strain BW25113 and acrB gene knockout strain BW25113∆acrB in order to

62

investigate the intracellular concentration of OH-PCBs. Based on our previous studies,
more OH-PCBs accumulated in BW25113∆acrB than in BW25113. However, the
above experiment could not differentiate the difference between OH-PCBs attached to
the cell membrane and those entered into the cell. By using this bioluminescent
whole-cell sensing system, we aimed at evaluating the differences of OH-PCB
concentrations in the cytoplasm of the two strains.

As shown in Figure 3.19, in the plasmid used in this study, hbpR, coding for
the regulator HbpR protein, is placed upstream of the promoter PhbpC and the reporter
luxAB, which codes for bacteria luciferase. In this way, the expression of luxAB is
activated by the promoter PhbpC, which is directly regulated by HbpR. In the absence
of OH-PCBs, HbpR binds with PhbpC, and prevents the expression of luciferase, while
the addition of OH-PCBs triggers a conformational change in HbpR to release the
promoter. As a result, expression of luxAB is induced. Bioluminescence is then
measured immediately after the addition of the substrate.

The mechanism involved in generating bioluminescence is shown in the
following reaction:

FMNH 2  RCHO  O2 luciferase

 FMN  RCPOOH  hv(500nm)

Bacteria luciferase catalyzes the monooxygenation of a long-chain aldehyde to
the corresponding carboxylic acid with production of light due to the decay of an
exited state intermediate. Here we used decanal as the substrate.
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Figure 3.19. Schematic representation of plasmid pHYBY109.

Important assay parameters were optimized in order to improve the
performance of the sensing system. Different incubation temperatures including 25 ºC,
30 ºC, and 37 ºC, incubation length including 3, 5, and 7 hours as well as cell
densities for the final bioluminescent assay were evaluated. Based on the sensitivity
of the instrument, the optimum conditions under which the strongest bioluminescent
signals can be measured, which are used in this study, are the following: the
incubation temperature and time were set at 30 ºC for 5 hours; optical densities of
cells in the final solution were at 3.0. The maximum bioluminescence emission
wavelength was determined to be 500 nm. Immediately after addition of the substrate
solution, the bioluminescent output was recorded. A bioluminescence emission curve
can be observed. A representative emission spectrum is shown in Figure 3.20.
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Figure 3.20. The bioluminescence emission curve of the whole-cell sensing system. The maximum
emission wavelength is 500 nm. Light output from 5 s to 30 s was integrated for quantification of
the bioluminescent signal. RLU, relative light unit.

We chose to work in the OH-PCB concentration range from 0.1 to 3.2 or 6.4
μg/ml, as higher OH-PCB concentration slowed down the growth of the knockout
strain, which is more sensitive to the toxicity of OH-PCBs. An increase of the
bioluminescent signals was detected with the increasing concentration of OH-PCBs,
consistent with results reported in literature [Turner, et al. 2007]. Bioluminescent
signals in both BW25113 and BW25113∆acrB were detected in the presence of four
concentrations of each OH-PCB (Figure 3.21).

Consistent with earlier toxicity and accumulation studies, different OH-PCBs
have different efficiency in inducing the bioluminescent signal (Figure 3.21).
However, all four OH-PCBs tested induced significantly higher signals in
BW25113∆acrB compared to BW25113. The stronger signals in BW25113∆acrB
suggested a higher cytoplasmic OH-PCB concentration in the acrB knockout strain.

For three OH-PCBs tested, HPCB2006, HPCB3001, and HPCB5001, the
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bioluminescent levels in the wild-type strain BW25113 were constant at different
OH-PCB level (Figure 3.21). For HPCB4002, an increase of OH-PCB concentration
in the cell culture did result in an increase of the bioluminescent signal. On the
contrary, all OH-PCBs induced the emission of bioluminescent signal in a
concentration dependent manner in BW25113∆acrB.

This result indicates that protein AcrB does interact with OH-PCBs and
functions on efflux these toxic compounds out of cells. Therefore, with absence of
protein AcrB, OH-PCBs are more likely to stay inside the cells and causing damage to
the cell.

A.
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Figure 3.21. Bioluminescent signal of BW25113 (orange) and BW25113∆acrB (blue) in the
presence of OH-PCBs: HPCB2006 (A), HPCB3001 (B), HPCB4002 (C), and HPCB5001 (D).
Data are the integration of bioluminescent signals from 5 s to 30 s divided by optical densities of
cells at 600 nm in the final testing solutions. RLU, relative light unit.
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Chapter IV: Conclusions

In this project, the interaction between a major multi-drug efflux transporter
protein, AcrB, and PCBs as well as their metabolites, OH-PCBs, was investigated
through the use of a wild-type E. coli strain BW25113 and its corresponding acrB
gene knockout strain BW25113∆acrB strain. I have found that PCBs have little toxic
effects to both E. coli strains, presumably due to low bioavailability. Different
OH-PCBs have distinguished levels of toxic effects. By measuring PCB and OH-PCB
accumulation in both cell strains using GC/MS, apparent differences were observed
between BW25113 and BW25113∆acrB. PCBs and OH-PCBs accumulate more in
BW25113∆acrB than in BW25113, suggesting protein AcrB functions in extruding
these compounds out of cells. The results are in agreement with the bioluminescent
assays using a whole-cell sensing system. With the same concentration of OH-PCBs
in the cell culture, a higher level of OH-PCBs enters the cytoplasm of
BW25113∆acrB than BW25113. My results indicate that PCBs and OH-PCBs are
likely to be substrates of protein AcrB. Therefore, AcrB can recognize and transport
PCBs and OH-PCBs out of cells. This finding suggests that the potential role of efflux
pumps should be considered while using microbes in bioremediation applications
involving PCBs and OH-PCBs.

Copyright © Shen Geng 2011
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